Used as a precursor in the synthesis of platinum-based anticancer agents, this compound plays a role in coordination chemistry for developing chemotherapeutic drugs. The diamine ligand stabilizes the platinum center, allowing for controlled reactivity and targeted delivery in medicinal applications. It is also employed in research settings to explore new platinum complexes with improved efficacy and reduced toxicity compared to existing treatments like cisplatin. Additionally, it serves as a building block in the preparation of catalysts for organic transformations, particularly in asymmetric synthesis where the cyclohexane backbone provides steric and chiral influence.